CMV UL94 Activators
The class of chemicals known as CMV UL94 modulators encompasses various antiviral compounds that, while not directly activating the UL94 protein, play a significant role in inhibiting or modulating the replication cycle of cytomegalovirus (CMV), potentially influencing the function or expression of UL94 indirectly. In the first paragraph of the description, we would explore how these compounds interfere with various stages of CMV replication. Antivirals like Ganciclovir, Foscarnet, and Cidofovir target the viral DNA polymerase, an essential enzyme for viral DNA synthesis. Inhibition of this enzyme effectively curtails the replication of the virus. Leflunomide, though its antiviral mechanism is less clear, has been observed to inhibit CMV replication. Maribavir targets the UL97 protein kinase of CMV, another crucial component in viral replication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
Has been shown to inhibit CMV replication, although its exact mechanism is not fully understood. | ||||||
Acyclovir | 59277-89-3 | sc-202906 sc-202906A | 50 mg 500 mg | $150.00 $940.00 | 2 | |
Primarily used for herpes simplex viruses but has some activity against CMV. | ||||||
Artesunate | 88495-63-0 | sc-201329 sc-201329A | 10 mg 50 mg | $62.00 $288.00 | 5 | |
An antimalarial with demonstrated effects against CMV in experimental studies. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An immunosuppressant that has shown antiviral activity against CMV. | ||||||